Table 3 Information on OR and PACU of the ERAS and control groups

Surgical duration (min, mean ± SD)

65.48 ± 16.32

63.94 ± 18.24

0.421

Intraoperative in-put (ml, median (IQR))

750.0(600.0–750.0)

750.0(750.0–837.5)

0.079

Intraoperative bleeding (ml, median (IQR))

15(10–20)

20(10–20)

0.411

Dose of remifentanil (μg, mean ± SD)

306 ± 105

358 ± 91

0.016

 Disorientation

6(10.17%)

14(38.89%)

0.001

 Sore throat

34(57.63%)

29(80.56%)

0.022

 Thirst

14(23.73%)

19(52.78%)

0.004

 Headache

0(0%)

1(2.78%)

0.198

 Chill

1(1.69%)

1(2.78%)

0.721

 Agitation

0(0%)

6(16.67%)

0.001